Prescribing HIV Pre-Exposure Prophylaxis (PrEP)
Pre-exposure prophylaxis (PrEP) is an effective way to prevent human immunodeficiency virus (HIV) transmission, yet it remains underprescribed.1Adams L, Balderson B. HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care. 2016;28(9):1154-1158. This course will walk the learner through the most important aspects of prescribing PrEP for patients at risk of HIV infection.
Learning Format: Internet activity, including mandatory assessment with a minimum passing level of 70% (number of questions varies by course).
Course created 2/27/2020. Last updated 2/27/2020.
At the end of this course, participants should be able to:
- Identify the indications, contraindications, and other important considerations for prescribing PrEP.
- Conduct a thorough evaluation to assess a patient’s candidacy for PrEP, including obtaining relevant history and laboratory testing.
- Identify important follow-up laboratory tests to obtain while a patient remains on PrEP.
- Incorporate PrEP prescription as part of a holistic approach to reducing HIV transmission risk.
The following persons state that they have no relevant financial relationships with commercial interests related to this course:
- Author: Haidn Foster, M.D.
- Reviewer: Sarah Pickle, M.D.
This course is not currently eligible for continuing medical education (CME) credit.
|↵1||Adams L, Balderson B. HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care. 2016;28(9):1154-1158.|